
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1063 | 1051 | 1177 | 1298 | 1546 | 1833 |
Fund Return | 6.31% | 5.1% | 17.72% | 9.09% | 9.11% | 6.25% |
Place in category | 305 | 315 | 220 | 147 | 109 | 78 |
% in Category | 57 | 56 | 42 | 28 | 27 | 25 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Royal London FTSE 350 Tracker Z Fun | 5.17B | 6.34 | 8.96 | 6.20 | ||
Royal London European Growth Fund C | 2.52B | 9.80 | 9.59 | 8.15 | ||
Royal London US Tracker Z Fund Accu | 1.25B | -1.33 | 14.21 | 14.47 | ||
Royal London UK Equity Income Fund | 1.15B | 5.19 | 9.30 | 6.39 | ||
Royal London UK Equity Income M | 1.15B | 5.17 | 9.23 | 6.34 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 14.79B | 6.89 | 8.27 | 6.15 | ||
VG UK Institutional Plus GBP Income | 14.79B | 9.34 | 5.75 | 6.11 | ||
All Share Index Unit Trust Income | 14.79B | 9.33 | 5.75 | 6.09 | ||
VG UK Plus GBP Accumulation | 14.79B | 9.34 | 5.76 | 6.12 | ||
UK Equity Tracker Fund D Acc | 12.42B | 6.05 | 8.74 | 6.23 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 6.64 | 11,316.0 | -1.19% | |
Shell | GB00BP6MXD84 | 6.30 | 33.37 | +1.52% | |
HSBC | GB0005405286 | 6.03 | 889.40 | +0.32% | |
ICF FTSE 100 IDX FUT MAR25 | GB00KNSR9V84 | 4.58 | - | - | |
Unilever | GB00B10RZP78 | 4.49 | 53.88 | +0.04% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | BUY | Strong Buy | Strong Buy |
Summary | Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review